EUVIMEDEUVIMED entdecken
Crossref

SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma

Xinying Chang, Cong Han, Haishuo Ji, Zhe Zeng, Jingyi Yang, Qirui Liu, Chao Jia, Lili Zhao, Chunlei Zhou, Shujia Chen, Wolfgang Knoll, Jia Li und 2 weitere

Analytica Chimica Acta · 2026

DOI: 10.1016/j.aca.2026.345209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Xinying Chang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Nankai International Advanced Research Institute (Shenzhen Futian), College of Life Sciences, Nan…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, MicroRNAs, CRISPR-Cas Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin Municipality, National Key Research and Development Program of China, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Accurate quantification of microRNAs (miRNAs) is essential for early cancer detection, yet remains challenging due to their short length, low abundance, and high sequence similarity. Existing assays often struggle to achieve sufficient sensitivity, specificity, and robustness for reliable clinical deployment. RESULTS: We introduce SPARC, a programmable molecular diagnostic platform that integrates a signal-triggered primer exchange reaction, self-supplied crRNA generation, and a tiered PER-transcription-CRISPR/Cas12a amplification cascade. Using miRNA-21 as a model, SPARC achieves an ultralow detection limit of 1.22 fM and a broad quantitative range from 1 fM to 100 nM. The system exhibits high specificity, strong analytical stability, and modular adaptability to diverse targets, including miRNA-122. Notably, the dual-directional profiling of oncogenic and tumor-suppressive miRNAs enhances diagnostic resolution. When applied to HCC cell lines and clinical tissues, SPARC accurately distinguished malignant from normal samples and showed excellent agreement with qRT-PCR measurements and histopathological assessments. SIGNIFICANCE: This streamlined and self-amplifying cascade system provides a scalable, robust, and clinically compatible platform for ultrasensitive miRNA detection. SPARC holds strong potential for early hepatocellular carcinoma screening, molecular subtyping, and broader precision oncology applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularMicroRNAsCRISPR-Cas SystemsEarly Detection of CancerMolecular Diagnostic TechniquesHumansNucleic Acid Amplification TechniquesTranscription, GeneticCell Line, Tumor

Stichwörter der Autor:innen

CRISPR/Cas12aHepatocellular carcinomaIsothermal amplificationPrimer exchange reactionmiRNA detection

Substanzen

MicroRNAsMIRN122 microRNA, human

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, Nankai International Advanced Research Institute (Shenzhen Futian), College of Life Sciences, Nankai University, Tianjin, 300350, PR China.
  • Department of Hepatology, Tianjin Second People's Hospital, Tianjin, 300192, PR China.
  • Department of Clinical Laboratory, Biological Sample Resource Sharing Center, Tianjin First Central Hospital, Nankai University, Tianjin, 300192, PR China.
  • Department of Chemistry and Physics of Materials, Faculty of Medicine and Dentistry, Danube Private University, Steiner Landstraße 124, Krems 3500, Austria.
  • Department of Hepatology, Tianjin Second People's Hospital, Tianjin, 300192, PR China. Electronic address: 18622663700@163.com.
  • Department of Clinical Laboratory, Biological Sample Resource Sharing Center, Tianjin First Central Hospital, Nankai University, Tianjin, 300192, PR China. Electronic address: 13920474643@163.com.

Förderung

  • Natural Science Foundation of Tianjin Municipality
  • National Key Research and Development Program of China
  • Key Technologies Research and Development Program

Zitieren

APA

Chang, X., Han, C., Ji, H., Zeng, Z., Yang, J., Liu, Q., Jia, C., Zhao, L., Zhou, C., Chen, S., Knoll, W., Li, J., Wang, Z., & Zhang, L. (2026). SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2026.345209

Vancouver

Chang X, Han C, Ji H, Zeng Z, Yang J, Liu Q, et al. SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2026.345209

BibTeX
@article{Chang2026,
  author = {Chang, Xinying and Han, Cong and Ji, Haishuo and Zeng, Zhe and Yang, Jingyi and Liu, Qirui and Jia, Chao and Zhao, Lili and Zhou, Chunlei and Chen, Shujia and Knoll, Wolfgang and Li, Jia and Wang, Zhenglu and Zhang, Liyun},
  title = {SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma},
  journal = {Analytica Chimica Acta},
  year = {2026},
  doi = {10.1016/j.aca.2026.345209}
}
Kostenlos starten →